Patents Represented by Attorney Richard A. Thompson
  • Patent number: 4175007
    Abstract: Antibiotic A21A is produced by cultivating Stneptomyces filipinesis under aerobic conditions.
    Type: Grant
    Filed: November 21, 1977
    Date of Patent: November 20, 1979
    Assignee: Merck & Co., Inc.
    Inventors: Sheldon B. Zimmerman, John H. Chalmers, Jr.
  • Patent number: 4172940
    Abstract: This case relates to a novel process for aiding in the isolation and purification of novel compounds which are produced by the microorganism, Streptomyces avermitilis. The process described herein utilizes a bed of activated alumina and a bed of activated carbon, respectively. The compounds which are isolated and purified are described generically as C-076 and have significant parasiticidal activity.
    Type: Grant
    Filed: October 3, 1977
    Date of Patent: October 30, 1979
    Assignee: Merck & Co., Inc.
    Inventor: Louis Chaiet
  • Patent number: 4168268
    Abstract: Fermentation broths or impure solutions containing thienamycin, a substance having antibiotic activity against gram-negative and gram-positive microorganisms, are isolated using liquid ion exchange systems.
    Type: Grant
    Filed: August 24, 1978
    Date of Patent: September 18, 1979
    Assignee: Merck & Co., Inc.
    Inventors: Rathin Datta, George T. Wildman
  • Patent number: 4161583
    Abstract: This case relates to a novel process which aids in the isolation and purification of novel compounds which are produced by the microorganism, Streptomyces avermitilis. The process described utilizes a non-aqueous extraction system for purifying crude extracts of the novel compounds. The compounds which are isolated and purified are described generically as C-076 and have significant parasiticidal activity.
    Type: Grant
    Filed: October 3, 1977
    Date of Patent: July 17, 1979
    Assignee: Merck & Co., Inc.
    Inventors: Kenneth E. Wilson, Thomas W. Miller
  • Patent number: 4160861
    Abstract: This case relates to a novel process which aids in the isolation and purification of novel compounds which are produced by the microorganism, Streptomyces avermitilis. The process described herein utilizes a high pressure liquid chromatographic system (HPLC) for the isolation and purification of the active compound. The compounds which are isolated and purified are described generically as C-076 and have significant parasiticidal activity.
    Type: Grant
    Filed: October 3, 1977
    Date of Patent: July 10, 1979
    Assignee: Merck & Co., Inc.
    Inventors: Douglas L. Cole, Robert T. Goegelman
  • Patent number: 4160084
    Abstract: This case relates to a novel process which aids in the isolation and purification of novel compounds which are produced by the microorganism, Streptomyces avermitilis. The process described utilizes a column containing a hydroxyalkylated dextran gel as a step in the separation of the desired compounds. The compounds which are isolated and purified are described generically as C-076 and have significant parasiticidal activity.
    Type: Grant
    Filed: October 11, 1977
    Date of Patent: July 3, 1979
    Assignee: Merck & Co., Inc.
    Inventors: Thomas W. Miller, Kenneth E. Wilson, Robert E. Ormond
  • Patent number: 4160083
    Abstract: This case relates to a novel process which aids in the isolation and purification of novel compounds which are produced by the microorganism, Streptomyces avermitilis. The process described herein utilizes a hydroxypropyl Sephadex column chromatographic step in the isolation of the compounds from broth. The compounds which are isolated and purified are described generically s C-076 and have significant parasiticidal activity.
    Type: Grant
    Filed: October 3, 1977
    Date of Patent: July 3, 1979
    Assignee: Merck & Co., Inc.
    Inventor: Lucille J. Cole
  • Patent number: 4144107
    Abstract: This invention relates to a gelled explosive and a method for its preparation. More specifically, the invention relates to a gelled explosive composition containing water, at least one member selected from the group of a polysaccharide colloid and synthetic polymer; water-soluble melamine resin and a water-soluble explosive salt.
    Type: Grant
    Filed: January 10, 1978
    Date of Patent: March 13, 1979
    Assignee: Merck & Co., Inc.
    Inventor: George T. Colegrove
  • Patent number: 4137405
    Abstract: Fermentation broths or impure solutions containing Cephamycin C, a substance having antibiotic activity against gram-negative and gram-positive microorganisms, are isolated using liquid anion exchange systems.
    Type: Grant
    Filed: July 28, 1977
    Date of Patent: January 30, 1979
    Assignee: Merck & Co., Inc.
    Inventors: George T. Wildman, Rathin Datta
  • Patent number: 4105605
    Abstract: A water-soluble anionic graft copolymer of xanthan gum and polyacrylamide wherein at least part of the amide function is sulfomethylated.
    Type: Grant
    Filed: December 21, 1976
    Date of Patent: August 8, 1978
    Assignee: Merck & Co., Inc.
    Inventors: Ian W. Cottrell, Richard A. Empey, Joseph S. Racciato
  • Patent number: 4081548
    Abstract: The antibiotic thienamycin is active against both gram-positive and gram-negative bacteria. The antibiotic is produced by growing a newly-found and hitherto undescribed species of Streptomyces on suitable fermentation media.
    Type: Grant
    Filed: September 3, 1976
    Date of Patent: March 28, 1978
    Assignee: Merck & Co., Inc.
    Inventors: Jean S. Kahan, Frederick M. Kahan, Edward O. Stapley, Robert T. Goegelman, Sebastian Hernandez
  • Patent number: 4071631
    Abstract: There is disclosed a new antibiotic A21A which is produced by cultivating the microorganism, Streptomyces filipinensis, in aqueous nutrient medium. The antibiotic has growth-improving activity.
    Type: Grant
    Filed: October 29, 1976
    Date of Patent: January 31, 1978
    Assignee: Merck & Co., Inc.
    Inventors: Sheldon B. Zimmerman, John H. Chalmers, Jr.
  • Patent number: 4065356
    Abstract: An antibiotic, designated FR-02A or efrotomycin, is obtained by culturing Streptomyces lactamdurans in a fermentation broth and extracting the whole broth with a water immiscible polar organic solvent to obtain the antibiotic FR-02A.
    Type: Grant
    Filed: March 1, 1977
    Date of Patent: December 27, 1977
    Assignee: Merck & Co., Inc.
    Inventors: William M. Maiese, Richard G. Wax
  • Patent number: 4055592
    Abstract: N-(Sulfo-lower alkyl)amides of (3-trifluoromethylphenoxy)-(4-chlorophenyl)acetic acid which are useful in the treatment of atherosclerosis. The N-(sulfo-lower alkyl)amides of (3-trifluoromethylphenoxy) (4-chlorophenyl)-acetic acid are prepared by reacting a (3-trifluoromethylphenoxy) (4-chlorophenyl)acetyl halide with an amino-lower alkanesulfonic acid.
    Type: Grant
    Filed: February 13, 1976
    Date of Patent: October 25, 1977
    Assignee: Merck & Co., Inc.
    Inventor: William A. Bolhofer
  • Patent number: 4055511
    Abstract: 4-Cyanothiazole is prepared by the catalytic vapor phase ammoxidation of .DELTA.3-4-methylthiazoline or 4-methylthiazole, using as catalyst a novel composition comprising a slurried chromium cobalt molybdate. The process affords high selectivity in the production of 4-cyanothiazole.
    Type: Grant
    Filed: March 15, 1976
    Date of Patent: October 25, 1977
    Assignee: Merck & Co., Inc.
    Inventors: Glenn R. Elion, Arthur E. Klink
  • Patent number: 4055514
    Abstract: 4-Cyanothiazole is prepared by the catalytic vapor phase ammoxidation of 4-methylthiazole using a novel catalyst composition comprising a cobalt molybdate catalyst wetted with different levels of potassium hydroxide. The process affords high selectivity to the desired 4-cyanothiazole.
    Type: Grant
    Filed: March 15, 1976
    Date of Patent: October 25, 1977
    Assignee: Merck & Co., Inc.
    Inventors: Glenn R. Elion, Arthur E. Klink
  • Patent number: 4053286
    Abstract: An improved process for preparing the compound 7.beta.-(2-thienylacetamido)-7-methoxy-3-carbamoyloxymethyl-3-cephem-4-car boxylic acid or its esters, from the compound 7.beta.-(D-5-amino-5-carboxyvaleramido)-3-carbamoyloxymethyl-7-methoxy-3-c ephem-4-carboxylic acid, by conducting the transacylation of the latter compound in the presence of commercially available alumino-silicate zeolites, also known as "molecular sieves." The process can be employed to prepare a cephalosporin with a desired 7-acylamido group from cephalosporins having a broad range of different 7-acylamido groups without having to isolate and purify a 7-amino intermediate. The final products have utility as broad spectrum antibiotics.
    Type: Grant
    Filed: May 24, 1976
    Date of Patent: October 11, 1977
    Assignee: Merck & Co., Inc.
    Inventor: Leonard M. Weinstock
  • Patent number: 4044133
    Abstract: Novel compounds of the following formula: ##STR1## wherein R' is alkyl of 1 to 3 carbon atoms, X.sup.- is a nontoxic anion; b and c are positive numbers having values such that the positive charge of b moles of cation are neutralized by c moles of anion X.sup.- ; and -.sup.+ is a bicyclic heterocyclic base, of the group consisting of: ##STR2## wherein the dotted lines indicates that the methyl group can be present or a hydrogen group can be present, with the proviso that the two alpha methyl groups are not present at the same time, but that one alpha methyl group is required. These compounds have superior coccidiostatic activity.
    Type: Grant
    Filed: October 16, 1975
    Date of Patent: August 23, 1977
    Assignee: Merck & Co., Inc.
    Inventors: Edward F. Rogers, John Hannah, Richard A. Dybas
  • Patent number: 4036696
    Abstract: A fermentation process for preparing 7-methoxy substituted cephalosporins. The products are useful as antibiotics and exhibit activity against gram-negative and gram-positive bacteria.
    Type: Grant
    Filed: June 14, 1976
    Date of Patent: July 19, 1977
    Assignee: Merck & Co., Inc.
    Inventors: Edward O. Stapley, Justo M. Mata
  • Patent number: 4024251
    Abstract: This invention relates to a new antibiotic agent which also possesses growth promoting activity. The antibiotic is isolated from the fermentation broth of Streptomyces lactamdurans by solvent extraction and designated Efrotomycin.
    Type: Grant
    Filed: February 12, 1976
    Date of Patent: May 17, 1977
    Assignee: Merck & Co., Inc.
    Inventors: William M. Maiese, Richard G. Wax